| Value | ₹339.4 Cr |
|---|
BSE filing, NSE: WELENT. Summary written from the filing by ALFA Finder's alert engine.
Welspun Enterprises Ltd: key numbers
- Share price
- ₹722.05
- Market cap
- ₹9,994 Cr
- Revenue (annual)
- ₹3,615 Cr
- Net profit (annual)
- ₹349.9 Cr
- P/E (TTM)
- 32.7×Sector 33.1×
- Promoter holding
- 56.13%+0.00% QoQ
- FII holding
- 7.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Welspun Enterprises Ltd
All →Welspun Enterprises Other Announcement
Welspun Enterprises filed its quarterly Regulation 32 statement confirming no deviation in use of its convertible warrant proceeds. The filing is a routine proceeds-utilisation statement with no new capital event.
Welspun Enterprises Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹1,035 Cr (+32% YoY), EBITDA ₹425 Cr (39.5% margin), PAT ₹296 Cr (+201%). H1 revenue +11%. Order book ₹18,708 Cr. AWEL gas evacuation approved via ONGC facilities.
Welspun Enterprises Management Change
Welspun Enterprises' board accepted the resignations of its CHRO and Company Secretary and appointed Ravi Singh as CHRO and Priya Pakhare as Company Secretary. These are senior management and KMP changes with no financial impact.
Welspun Enterprises Q2 FY27 Results: Net Profit ₹295.6 Cr, Up 201.3% YoY
Welspun Enterprises Ltd reported revenue from operations of ₹1,035 Cr (+32.0% YoY) and net profit of ₹295.6 Cr (+201.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹295.6 Cr · +201.3% YoY
Welspun Enterprises Board Meeting Date
Welspun Enterprises intimated a board meeting on 05-11-2026 to consider unaudited standalone and consolidated half-year results for September 2026. Trading window is closed from 01-10-2026 to 07-11-2026.
Welspun Enterprises Other Announcement
Welspun Enterprises Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Other merger & restructuring announcements
All →Eiko Lifesciences Merger & Restructuring
Eiko Lifesciences' wholly owned subsidiary Eiko Scientific Solutions LLP will form a 50:50 joint venture, Oval Eiko Resources, with Oval Projects Engineering. The JV targets compressed bio gas production and distribution.
Rashi Peripherals Merger & Restructuring
Rashi Peripherals' board approved a share purchase and shareholders' agreement to sell 26% of subsidiary Rashi Semiconductor Solutions to Restar Corporation, Japan. Execution remains subject to approvals.
Span Divergent Merger & Restructuring Worth ₹5 Cr
Span Divergent's board approved selling its Mumbai immovable property to Glorious Sales LLP, an unrelated buyer, for up to Rs.5 Crore. Completion is expected by March 31, 2027.
- Value
- ₹5.00 Cr
- Execution
- Agreement to be executed on or before March 31, 2027; sale expected to complete on or before March 31, 2027
Sunteck Realty Merger & Restructuring Worth ₹0.01 Cr
Sunteck Realty incorporated a wholly owned subsidiary, Eminara Real Estates Private Limited. The Rs 1 lakh subscription is a small real estate expansion step.
- Value
- ₹0.01 Cr
Enviro Infra Engineers Merger & Restructuring Worth ₹0.01 Cr
Enviro Infra Engineers Limited, through its step-down subsidiary arrangement, incorporated WINDAXIS RENEWABLES PRIVATE LIMITED, a renewable power venture, with Rs.0.01 Crore cash consideration for 51% stake. The new entity will pursue wind, hydro and biomass power projects.
- Value
- ₹0.01 Cr
Enviro Infra Engineers Merger & Restructuring
Enviro Infra Engineers' step-down subsidiary Suyog Urja incorporated a wholly owned subsidiary, Windaxis Renewables, for wind and renewable power generation. The filing is an incorporation intimation with no stated capital outlay beyond nominal authorised capital.